United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 23, 2026 · Filed Sep 24, 2026

On Sep 23, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$491.57 for US$4.67M under a trading plan, leaving 324,443 shares. Filed Sep 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$491.57 average (US$488.70 to US$500.05)
Value
US$4.67M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 23, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 23, 2026Common StockSale2,388US$488.70331,555Indirect
Sep 23, 2026Common StockSale2,162US$489.52329,393Indirect
Sep 23, 2026Common StockSale1,440US$490.48327,953Indirect
Sep 23, 2026Common StockSale824US$491.65327,129Indirect
Sep 23, 2026Common StockSale480US$492.54326,649Indirect
Sep 23, 2026Common StockSale160US$493.72326,489Indirect
Sep 23, 2026Common StockSale155US$495.17326,334Indirect
Sep 23, 2026Common StockSale525US$496.38325,809Indirect
Sep 23, 2026Common StockSale766US$497.27325,043Indirect
Sep 23, 2026Common StockSale270US$498.38324,773Indirect
Sep 23, 2026Common StockSale90US$498.90324,683Indirect
Sep 23, 2026Common StockSale240US$500.05324,443Indirect

Source

View original at SEC

Related